SoftMaxx AI sells no peptides and takes no vendor money.
Human, small or uncontrolled We found no trial of SNAP-8, which is acetyl octapeptide-3 as sellers describe it, on its own. The one human study we found tested an eye patch with acetyl octapeptide-3, a vitamin C derivative and cyclic lysophosphatidic acid, against a hyaluronic-acid placebo patch, in 24 people over 28 days.[1]
What SNAP-8 is
As sellers describe it, SNAP-8 is acetyl octapeptide-3; we found no regulator record or study that names SNAP-8. The EU cosmetic-ingredient database (CosIng) lists acetyl octapeptide-3 as 'the reaction product of acetic acid and Octapeptide-3', with the functions humectant and skin conditioning per its CosIng entry [3]. We found no study of injected SNAP-8.
- In vitro (cells) (argireline data) These data are for argireline, a different peptide. Argireline is patterned on the N-terminal end of SNAP-25 [4] and, in its developers' lab tests, interfered with the SNARE complex and inhibited neurotransmitter release with much lower efficacy than botulinum toxin A [5]. In human cadaver skin, most of the applied argireline washed off the surface, what penetrated stayed mostly in the stratum corneum, and none was detected in the dermis [6], and a 2025 review calls its ability to reach nerve–muscle junctions uncertain [7]. We found no study of how far SNAP-8 itself gets into skin.[4][5][6][7]
Claims vs. evidence
Each popular claim, graded by the strongest study behind it. The words in quotation marks are how the claim is marketed; the text after the grade is what the studies show.
- Claim as marketed
Reduces expression lines (topical)
Human, small or uncontrolled Microneedle patch with acetyl octapeptide-3 plus a vitamin C derivative and cyclic lysophosphatidic acid, against a hyaluronic-acid-only placebo patch, one eye each, applied overnight and assessed over 28 days (n=24); the peptide's contribution was not isolated.[1] - Claim as marketed
Botox-like muscle relaxation
In vitro (cells) (argireline data) The nearest data are argireline lab work, where argireline inhibited neurotransmitter release with much lower efficacy than botulinum toxin A. We found no study measuring muscle activity after topical SNAP-8.[5] - Claim as marketed
Injectable SNAP-8 for wrinkles
No supporting study We found no published human or animal study of injected SNAP-8. A 2026 review warns that unregulated injectable peptides carry risks of product contamination, manufacturing impurities and inaccurate dosing.[8]
Common myths, checked
- Common belief
SNAP-8 is a topical Botox.
In vitro (cells) (argireline data) The nearest data are argireline lab work, where argireline inhibited nerve-signal release with much lower efficacy than botulinum toxin A. In lab tests on human skin, most of the applied argireline washed off the surface and what penetrated stayed mostly in the skin's outer layer; we found no study showing SNAP-8 reaches or relaxes facial muscles.[5][6][7] - Common belief
Injecting SNAP-8 is a safe, stronger way to use it.
Expert review We found no published human or animal study of injected SNAP-8. A 2026 review warns that unregulated injectable peptides carry risks of product contamination, manufacturing impurities and inaccurate dosing.[8]
Doses used in studies (not a recommendation)
Each row comes from the cited source: a study dose, a safety-review limit or a registered trial's planned dose, as labelled. Where the abstract states no amount, the row says so. They are a record of what was reported, not dosing instructions, and nothing here says what you should take.
| Studied in | Route | Amount reported | How often | How long | n | Source |
|---|---|---|---|---|---|---|
| Humans | topical via dissolving microneedle patch (periorbital) | acetyl octapeptide-3 content not stated in abstract (multi-ingredient patch) Study dose | overnight (number of applications not stated in abstract) | 28 days | 24 | [1] 24 healthy subjects; active patch on one eye, placebo patch on the other |
Side effects and risks
Regulatory status (checked 2026-10-01 to 2026-10-03)
- United States (FDA)We found no FDA-approved product containing SNAP-8 in Drugs@FDA (searched 2026-10-01). (FDA:
Drugs@FDA search: snap-8 — no approved product found
, captured 2026-10-01) Under the FD&C Act, cosmetic products and ingredients, with the exception of color additives, do not require FDA approval before they go on the market; the Act defines drugs, in part, by their intended use, including “articles (other than food) intended to affect the structure or any function of the body of man or other animals”, and some products meet the definitions of both cosmetics and drugs. (FDA:Is It a Cosmetic, a Drug, or Both?
, captured 2026-10-03) - CanadaWe found no product containing SNAP-8 in Health Canada’s Drug Product Database (searched 2026-10-01). (Health Canada:
Health Canada Drug Product Database search: snap-8 — no product found
, captured 2026-10-01) - Sport (WADA)WADA’s Prohibited List does not name SNAP-8. WADA states that topical cosmetic products may contain prohibited peptides or growth factors and that using cosmetic products containing such substances is prohibited; we found no WADA statement on whether SNAP-8 is one of them. (WADA:
World Anti-Doping Code International Standard Prohibited List 2026
, captured 2026-10-03; WADA:The Prohibited List
, captured 2026-10-03)
Official sources: FDA: Is It a Cosmetic, a Drug, or Both?
· WADA: World Anti-Doping Code International Standard Prohibited List 2026
· WADA: The Prohibited List
Report a side effect
If something went wrong after using a health product, tell a clinician. Report side effects to:
- FDA MedWatch (United States)
- Health Canada (report a side effect)
Common questions
Is SNAP-8 Botox?
In vitro (cells) No. CosIng lists acetyl octapeptide-3, which is SNAP-8 as sellers describe it, as the reaction product of acetic acid and octapeptide-3 per its CosIng entry [3], not a botulinum toxin. A 2025 review notes that acetyl hexapeptide-8 (Argireline), a different peptide, is often referred to as a "botox-like" peptide [7]; in lab tests it inhibited neurotransmitter release with much lower efficacy than botulinum toxin A [5]. We found no study measuring muscle activity after topical SNAP-8, and the one human study we found tested a multi-ingredient patch.[5][1]
SNAP-8 peptide injection side effects?
Expert review A 2026 review warns that unregulated injectable peptides carry risks of product contamination, manufacturing impurities and inaccurate dosing. We found no human safety study of injected SNAP-8.[8]
References
References to papers were matched to their PubMed or DOI records. Regulator, label and registry pages were fetched and saved by us; each status line under Regulatory status gives the date its source was captured. "Verified" means the paper exists and is the one named; what it supports is stated next to each claim.
Clinical Safety and Efficacy Evaluation of a Dissolving Microneedle Patch Having Dual Anti-Wrinkle Effects With Safe and Long-Term Activities.
PubMed 39082657 DOIPublic Interest in Acetyl Hexapeptide-8: Longitudinal Analysis.
PubMed 38376906 DOIEU CosIng ingredient record: ACETYL OCTAPEPTIDE-3
SourceThe anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects: a randomized, placebo-controlled study.
PubMed 23417317 DOIA synthetic hexapeptide (Argireline) with antiwrinkle activity.
PubMed 18498523 DOIIn vitro skin penetration of acetyl hexapeptide-8 from a cosmetic formulation.
PubMed 24754410 DOIAcetyl Hexapeptide-8 in Cosmeceuticals-A Review of Skin Permeability and Efficacy.
PubMed 40565185 DOIDangers of Injectable Peptides and Other Unregulated "Biohacking" Drugs.
PubMed 42757290
Keep reading
- Best peptides for skin, ranked by evidence→
- Copper peptides vs retinol: what the evidence shows→
- Peptides for looksmaxxing: what the evidence actually shows→
- GHK-Cu (copper tripeptide-1): what the evidence shows→
- Argireline (acetyl hexapeptide-8): what the evidence shows→
- Matrixyl: what the cited trials of palmitoyl pentapeptides show→
- All peptide pages, by evidence→